“It's the genes, stupid” Molecular bases and clinical consequences of genetic cytochrome P450 2D6 polymorphism

This publication has 74 references indexed in Scilit:

• Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI)
  Published by Elsevier ,2005
• Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotype
  Human Molecular Genetics, 1994
• Evidence for a new variant CYP2D6 allele CYP2D6J in a Japanese population associated with lower in vivo rates of sparteine metabolism
  Pharmacogenetics, 1993
• Involvement of CYP2D6 in Oxidative Metabolism of Cinnarizine and Flunarizine in Human Liver Microsomes
  Biochemical and Biophysical Research Communications, 1993
• Genetic polymorphism of cytochromes P450: Interethnic differences and relationship to incidence of lung cancer
  Pharmacogenetics, 1992
• Identification of a new variant CYP2D6 allele lacking the codon encoding Lys-281: possible association with the poor metabolizer phenotype
  Pharmacogenetics, 1991
• Clinical Pharmacokinetics of Clomipramine
  Clinical Pharmacokinetics, 1991
• Role of genetics and drug metabolism in human cancer risk
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1991
• Pharmacokinetics of N-propylajmaline in relation to polymorphic sparteine oxidation
  Journal of Molecular Medicine, 1985
• Interindividual and interspecies variation in the metabolism of the hallucinogen 4-methoxyamphetamine
  Xenobiotica, 1979